StemCells Inc Share Price Nasdaq
Stocks
US85857R3030
Biotechnology & Medical Research
| Market Cap | 9.07Cr 7.92Cr 7.45Cr 6.8Cr 13Cr 866.8Cr 13Cr 89Cr 34Cr 442.66Cr 34Cr 33Cr 1.43TCr | P/E 2026 * |
-4.5x | P/E 2027 * | -4.71x |
|---|---|---|---|---|---|
| Enterprise Value | 9.07Cr 7.92Cr 7.45Cr 6.8Cr 13Cr 866.8Cr 13Cr 89Cr 34Cr 442.66Cr 34Cr 33Cr 1.43TCr | EV / Sales 2026 * |
50.4x | EV / Sales 2027 * | 8.89x |
| Free-Float |
100% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: StemCells Inc
| 1 day | -19.35% |
| Manager | Title | Age | Since |
|---|---|---|---|
Harel Gadot
CEO | Chief Executive Officer | 54 | 02/08/1988 |
Rachel Vaknin
DFI | Director of Finance/CFO | 47 | 01/04/2022 |
Michal Ahuvia
COO | Chief Operating Officer | - | 21/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Harel Gadot
CHM | Chairman | 54 | 01/01/2013 |
Scott Burell
BRD | Director/Board Member | 61 | 28/11/2016 |
Martin Madden
BRD | Director/Board Member | 65 | 06/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -19.35% | +575.21% | - | - | 9.07Cr | |
| +2.55% | +4.77% | +4.07% | +32.02% | 4.67TCr | |
| +0.46% | +0.58% | +44.41% | +36.47% | 4.44TCr | |
| -0.07% | -6.38% | +331.88% | +539.33% | 4.13TCr | |
| +0.40% | +5.48% | +8.19% | +91.77% | 4.16TCr | |
| -1.60% | -0.17% | +9.73% | +43.63% | 3.01TCr | |
| +0.66% | +1.76% | +26.77% | +160.17% | 1.74TCr | |
| -0.86% | -1.62% | - | - | 1.56TCr | |
| +1.15% | +7.46% | +25.97% | +43.93% | 1.55TCr | |
| -0.76% | +13.19% | -9.25% | - | 1.41TCr | |
| Average | -1.78% | +3.39% | +55.22% | +135.33% | 2.96TCr | |
| Weighted average by Cap. | +0.35% | +1.94% | +68.67% | +143.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 17.99L 15.72L 14.77L 13.48L 25.3L 17Cr 25.31L 1.77Cr 68.42L 8.78Cr 67.55L 66.07L 28Cr | 1.02Cr 89.14L 83.78L 76.45L 1.43Cr 98Cr 1.44Cr 10Cr 3.88Cr 50Cr 3.83Cr 3.75Cr 160.53Cr |
| Net income | -2.04Cr -1.79Cr -1.68Cr -1.53Cr -2.87Cr -195.33Cr -2.87Cr -20Cr -7.77Cr -100Cr -7.67Cr -7.51Cr -321.58Cr | -1.94Cr -1.7Cr -1.6Cr -1.46Cr -2.73Cr -185.68Cr -2.73Cr -19Cr -7.39Cr -95Cr -7.29Cr -7.13Cr -305.69Cr |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
